← Back
Data updated: Mar 10, 2026
KAI PHARMS INC
Metabolic
KAI PHARMS INC is a pharmaceutical company focused on Metabolic. Key products include PARSABIV.
2017
Since
1
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2017-02-07
- Latest
- 2021-02-11
- Applications
- 1